5,132 followers
RT @ivybelkins: This underlines why it is so critically important for @EGFRResisters who progress on osimertinib to get repeat biopsies and…
Showing items 1–100
64 followers
RT @geoff_oxnard: Agreed! Fusions in RET, ALK, BRAF, FGFR all appear targetable in EGFR resistance @EGFRResisters, are a key component to r…
589 followers
RT @geoff_oxnard: Agreed! Fusions in RET, ALK, BRAF, FGFR all appear targetable in EGFR resistance @EGFRResisters, are a key component to r…
1,566 followers
RT @geoff_oxnard: Agreed! Fusions in RET, ALK, BRAF, FGFR all appear targetable in EGFR resistance @EGFRResisters, are a key component to r…
7,599 followers
RT @geoff_oxnard: Agreed! Fusions in RET, ALK, BRAF, FGFR all appear targetable in EGFR resistance @EGFRResisters, are a key component to r…
3,885 followers
RT @ivybelkins: This underlines why it is so critically important for @EGFRResisters who progress on osimertinib to get repeat biopsies and…
100 followers
RT @geoff_oxnard: Agreed! Fusions in RET, ALK, BRAF, FGFR all appear targetable in EGFR resistance @EGFRResisters, are a key component to r…
922 followers
RT @geoff_oxnard: Agreed! Fusions in RET, ALK, BRAF, FGFR all appear targetable in EGFR resistance @EGFRResisters, are a key component to r…
301 followers
RT @geoff_oxnard: Agreed! Fusions in RET, ALK, BRAF, FGFR all appear targetable in EGFR resistance @EGFRResisters, are a key component to r…
1,119 followers
RT @geoff_oxnard: Agreed! Fusions in RET, ALK, BRAF, FGFR all appear targetable in EGFR resistance @EGFRResisters, are a key component to r…
5,132 followers
RT @geoff_oxnard: Agreed! Fusions in RET, ALK, BRAF, FGFR all appear targetable in EGFR resistance @EGFRResisters, are a key component to r…
922 followers
RT @ivybelkins: This underlines why it is so critically important for @EGFRResisters who progress on osimertinib to get repeat biopsies and…
3,816 followers
RT @ivybelkins: This underlines why it is so critically important for @EGFRResisters who progress on osimertinib to get repeat biopsies and…
3,816 followers
RT @geoff_oxnard: Agreed! Fusions in RET, ALK, BRAF, FGFR all appear targetable in EGFR resistance @EGFRResisters, are a key component to r…
5,286 followers
This underlines why it is so critically important for @EGFRResisters who progress on osimertinib to get repeat biopsies and biomarker testing. Ask to make sure your testing will uncover fusions that may be resistance mechanisms! #lcsm #EGFR #lungcancer
3,699 followers
Agreed! Fusions in RET, ALK, BRAF, FGFR all appear targetable in EGFR resistance @EGFRResisters, are a key component to resistance profiling, and should be detectable with an appropriately designed LBx: https://t.co/usnGP5cMQ0
3,699 followers
Exciting to see this path forward. Hey @JLimMD let's target BRAF fusions! Seeing these more and more, even in ctDNA. More data to come at ASCO GU w @montypal @neerajaiims @EAntonarakis! https://t.co/46CeUuRGqJ
854 followers
RT @SewantiLimaye: Targetable kinase fusions are identified in ctDNA across cancer types. In pairs with tissue-identified fusions, fusion d…
262 followers
RT @SewantiLimaye: Targetable kinase fusions are identified in ctDNA across cancer types. In pairs with tissue-identified fusions, fusion d…
2,239 followers
RT @SewantiLimaye: Targetable kinase fusions are identified in ctDNA across cancer types. In pairs with tissue-identified fusions, fusion d…
2,594 followers
Targetable kinase fusions are identified in ctDNA across cancer types. In pairs with tissue-identified fusions, fusion detection in ctDNA is reliable with elevated ctDNA fraction.
39 followers
RT @AndresFCardonaZ: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA https://t.co/XbACsOYLOX
7,599 followers
The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA https://t.co/XbACsOYLOX
196 followers
RT @geoff_oxnard: Another report showing ~30% failure rate of RNAseq in NSCLC. Highlights the role of well designed hybrid capture DNAseq f…
2,986 followers
RT @geoff_oxnard: Another report showing ~30% failure rate of RNAseq in NSCLC. Highlights the role of well designed hybrid capture DNAseq f…
687 followers
RT @geoff_oxnard: Another report showing ~30% failure rate of RNAseq in NSCLC. Highlights the role of well designed hybrid capture DNAseq f…
5,621 followers
RT @geoff_oxnard: Another report showing ~30% failure rate of RNAseq in NSCLC. Highlights the role of well designed hybrid capture DNAseq f…
388 followers
RT @geoff_oxnard: Another report showing ~30% failure rate of RNAseq in NSCLC. Highlights the role of well designed hybrid capture DNAseq f…
1,278 followers
RT @geoff_oxnard: Another report showing ~30% failure rate of RNAseq in NSCLC. Highlights the role of well designed hybrid capture DNAseq f…
7,599 followers
RT @geoff_oxnard: Another report showing ~30% failure rate of RNAseq in NSCLC. Highlights the role of well designed hybrid capture DNAseq f…
3,699 followers
Another report showing ~30% failure rate of RNAseq in NSCLC. Highlights the role of well designed hybrid capture DNAseq for reliable detection of diverse fusions and partners across tissue and ctDNA. https://t.co/usnGP5unHy
2,925 followers
RT @geoff_oxnard: The goal is for TF to identify a high shed state where we can have a confident neg LBx result (high NPV). Requires (1) an…
430 followers
RT @geoff_oxnard: The goal is for TF to identify a high shed state where we can have a confident neg LBx result (high NPV). Requires (1) an…
2,552 followers
RT @geoff_oxnard: The goal is for TF to identify a high shed state where we can have a confident neg LBx result (high NPV). Requires (1) an…
4,919 followers
RT @geoff_oxnard: The goal is for TF to identify a high shed state where we can have a confident neg LBx result (high NPV). Requires (1) an…
3,699 followers
The goal is for TF to identify a high shed state where we can have a confident neg LBx result (high NPV). Requires (1) an accurate TF estimation and (2) reliable sensitivity w elevated TF. Reliable fusion sensitivity is key: https://t.co/usnGP5dkFy https:/
6,825 followers
RT @geoff_oxnard: @DanaFarber @jberchuck BTW was just looking at our previously published FGFR2 fusion liquid biopsy data in @CCR_AACR. See…
3,699 followers
@DanaFarber @jberchuck BTW was just looking at our previously published FGFR2 fusion liquid biopsy data in @CCR_AACR. Seems like we see a fair diversity of fusions partners, mostly non-BICC1 FGFR2 fusions: https://t.co/usnGP5dkFy https://t.co/Xk2T7BB3Uy
35 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
6,825 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
1,566 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
3,699 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
4,919 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
23,108 followers
The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @FoundationATCG @CCR_AACR https://t.co/grnEvyPtkg #PrecisionMedicine #ctDNA HT @ADesaiMD https://t.co/tdzfMj9EUt
268 followers
RT @BenWestphalen: Liquid biopsy #researchpaper in @CCR_AACR Almost 37K samples analysed; focus on targetable fusions; 88% ctDNA✅ - 1,8%…
462 followers
RT @BenWestphalen: Liquid biopsy #researchpaper in @CCR_AACR Almost 37K samples analysed; focus on targetable fusions; 88% ctDNA✅ - 1,8%…
6,825 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Founda…
4,919 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Founda…
23,108 followers
The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @FoundationATCG @CCR_AACR https://t.co/grnEvyOVuI #PrecisionMedicine #ctDNA HT @ADesaiMD
497 followers
RT @BenWestphalen: Liquid biopsy #researchpaper in @CCR_AACR Almost 37K samples analysed; focus on targetable fusions; 88% ctDNA✅ - 1,8%…
2,058 followers
RT @BenWestphalen: Liquid biopsy #researchpaper in @CCR_AACR Almost 37K samples analysed; focus on targetable fusions; 88% ctDNA✅ - 1,8%…
653 followers
RT @BenWestphalen: Liquid biopsy #researchpaper in @CCR_AACR Almost 37K samples analysed; focus on targetable fusions; 88% ctDNA✅ - 1,8%…
34,583 followers
RT @BenWestphalen: Liquid biopsy #researchpaper in @CCR_AACR Almost 37K samples analysed; focus on targetable fusions; 88% ctDNA✅ - 1,8%…
6,825 followers
RT @BenWestphalen: Liquid biopsy #researchpaper in @CCR_AACR Almost 37K samples analysed; focus on targetable fusions; 88% ctDNA✅ - 1,8%…
3,699 followers
RT @BenWestphalen: Liquid biopsy #researchpaper in @CCR_AACR Almost 37K samples analysed; focus on targetable fusions; 88% ctDNA✅ - 1,8%…
2,239 followers
RT @BenWestphalen: Liquid biopsy #researchpaper in @CCR_AACR Almost 37K samples analysed; focus on targetable fusions; 88% ctDNA✅ - 1,8%…
4,303 followers
Liquid biopsy #researchpaper in @CCR_AACR Almost 37K samples analysed; focus on targetable fusions; 88% ctDNA✅ - 1,8% w fusions; most frequent in cholangiocarcinoma, bladder & lung #cancer. @OncoAlert 🚨#PrecisionMedicine Check out the #OpenAccess
49 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
372 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
198 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
264 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
533 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
687 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
1,566 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
6,825 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
5,130 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
4,919 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
3,699 followers
RT @mtmdphd: The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @Foundat…
23,108 followers
The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA [Jan 10, 2022] Lee et al. @geoff_oxnard @FoundationATCG @CCR_AACR https://t.co/grnEvyOVuI #PrecisionMedicine #ctDNA HT @ADesaiMD https://t.co/8qMzYcsfPj
7,428 followers
The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA https://t.co/yF4L28KCeL
6 followers
RT @FoundationATCG: New research in @CCR_AACR shows our liquid biopsy test provides pan-tumor detection of kinase fusions in ctDNA, which a…
3,699 followers
RT @FoundationATCG: New research in @CCR_AACR shows our liquid biopsy test provides pan-tumor detection of kinase fusions in ctDNA, which a…
168 followers
RT @FoundationATCG: New research in @CCR_AACR shows our liquid biopsy test provides pan-tumor detection of kinase fusions in ctDNA, which a…
376 followers
RT @FoundationATCG: New research in @CCR_AACR shows our liquid biopsy test provides pan-tumor detection of kinase fusions in ctDNA, which a…
6,825 followers
RT @FoundationATCG: New research in @CCR_AACR shows our liquid biopsy test provides pan-tumor detection of kinase fusions in ctDNA, which a…
751 followers
RT @FoundationATCG: New research in @CCR_AACR shows our liquid biopsy test provides pan-tumor detection of kinase fusions in ctDNA, which a…
10,203 followers
New research in @CCR_AACR shows our liquid biopsy test provides pan-tumor detection of kinase fusions in ctDNA, which are historically challenging to uncover using liquid biopsy. Read more: https://t.co/9LgdpjmRZC https://t.co/MiP9UsobdO
20 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
3,699 followers
@lgreco_ny @oncologician @StephenVLiu Agree rare can be hard to quantify. Fortunately HIP1-ALK is a recurring fusion that can be detected with comprehensive DNA assays, both tissue and liquid. Some cases in Supp Figure 3 in our recent ctDNA fusion paper: h
198 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
121 followers
RT @geoff_oxnard: So excited to publish w @FoundationATCG on 'The pan-tumor landscape of targetable kinase fusions in ctDNA' in @CCR_AACR:…
372 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
10,303 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
687 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
56 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
111 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
808 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
3,097 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
35 followers
RT @RUT_hhshark: 読む 癌腫横断3万例以上におけるctDNAによる融合遺伝子の検出 /Clinical Cancer Research https://t.co/I3tXFqashb 36916例：F1 Liquid実施 32492例：ctDNA検出 517例…
166 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
32 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
407 followers
RT @AriellaHanker: Don't ignore the fusions! Rare in #breastcancer but potentially targetable! Favorites including #ERBB2, #FGFR1/2/3. #Pre…
748 followers
RT @geoff_oxnard: So excited to publish w @FoundationATCG on 'The pan-tumor landscape of targetable kinase fusions in ctDNA' in @CCR_AACR:…
174 followers
RT @geoff_oxnard: So excited to publish w @FoundationATCG on 'The pan-tumor landscape of targetable kinase fusions in ctDNA' in @CCR_AACR:…
228 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
10 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
3,699 followers
RT @jsoriamd: #Liquidbiopsies can detect mutations but not always kinase fusions. This manuscript describes the pan-tumor landscape of tar…
274 followers
RT @RUT_hhshark: 読む 癌腫横断3万例以上におけるctDNAによる融合遺伝子の検出 /Clinical Cancer Research https://t.co/I3tXFqashb 36916例：F1 Liquid実施 32492例：ctDNA検出 517例…
956 followers
RT @RUT_hhshark: 読む 癌腫横断3万例以上におけるctDNAによる融合遺伝子の検出 /Clinical Cancer Research https://t.co/I3tXFqashb 36916例：F1 Liquid実施 32492例：ctDNA検出 517例…
222 followers
RT @RUT_hhshark: 読む 癌腫横断3万例以上におけるctDNAによる融合遺伝子の検出 /Clinical Cancer Research https://t.co/I3tXFqashb 36916例：F1 Liquid実施 32492例：ctDNA検出 517例…
Showing items 1–100